Dose–Response Relationship Between BMI and Hyperuricemia

References

• Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007–2008. Arthritis Rheum. 2011;63(10):3136–3141. doi:10.1002/art.30520
   PubMed Web of Science ®Google Scholar
• Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int. 2015;2015:762820. doi:10.1155/2015/762820
   PubMed Web of Science ®Google Scholar
• Nagahama K, Iseki K, Inoue T, et al. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res. 2004;27(4):227–233. doi:10.1291/hypres.27.227
   PubMed Web of Science ®Google Scholar
• Bardin T, Richette P. Definition of hyperuricemia and gouty conditions. Curr Opin Rheumatol. 2014;26(2):186–191. doi:10.1097/BOR.0000000000000028
   PubMed Web of Science ®Google Scholar
• Edwards NL. The role of hyperuricemia in vascular disorders. Curr Opin Rheumatol. 2009;21(2):132–137. doi:10.1097/BOR.0b013e3283257b96
   PubMed Web of Science ®Google Scholar
• Kleber ME, Delgado G, Grammer TB, et al. Uric acid and cardiovascular events: a Mendelian randomization study. J Am Soc Nephrol. 2015;26(11):2831–2838. doi:10.1681/ASN.2014070660
   PubMed Web of Science ®Google Scholar
• Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811–1821. doi:10.1056/NEJMra0800885
   PubMed Web of Science ®Google Scholar
• Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis. 2009;202(1):11–17. doi:10.1016/j.atherosclerosis.2008.05.022
   PubMed Web of Science ®Google Scholar
• Jing J, Kielstein JT, Schultheiss UT, et al. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study. Nephrol Dial Transplant. 2015;30(4):613–621. doi:10.1093/ndt/gfu352
   PubMed Web of Science ®Google Scholar
• Juraschek SP, Kovell LC, Miller ER, et al. Association of kidney disease with prevalent gout in the United States in 1988–1994 and 2007–2010. Semin Arthritis Rheum. 2013;42(6):551–561. doi:10.1016/j.semarthrit.2012.09.009
   PubMed Web of Science ®Google Scholar
• Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One. 2013;8(2):e56864. doi:10.1371/journal.pone.0056864
   PubMed Web of Science ®Google Scholar
• Grayson PC, Kim SY, LaValley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res. 2011;63(1):102–110. doi:10.1002/acr.20344
   PubMed Web of Science ®Google Scholar
• Liu H, Zhang XM, Wang YL, et al. Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol. 2014;27(6):653–658. doi:10.1007/s40620-014-0082-z
   PubMed Web of Science ®Google Scholar
• Song P, Wang H, Xia W, et al. Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China. Sci Rep. 2018;8(1):4314. doi:10.1038/s41598-018-22570-9
   PubMed Web of Science ®Google Scholar
• Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on Bangladeshi adults. PLoS One. 2018;13(11):e0206850. doi:10.1371/journal.pone.0206850
   PubMed Web of Science ®Google Scholar
• Kuwabara M, Kuwabara R, Niwa K, et al. Different risk for hypertension, diabetes, dyslipidemia, and hyperuricemia according to level of body mass index in Japanese and American subjects. Nutrients. 2018;10(8):1011. doi:10.3390/nu10081011
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–68. doi:10.1093/ije/dys203
   PubMed Web of Science ®Google Scholar
• Chen C, Lu FC; P.R.C. Department of Disease Control Ministry of Health. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17:1–36.
   PubMed Web of Science ®Google Scholar
• Yan M, Fu Z, Qin T, et al. Associations of sleep duration and prediabetes prevalence in a middle-aged and elderly Chinese population with regard to age and hypertension: the China Health and Retirement Longitudinal Study baseline survey. J Diabetes. 2018;10(11):847–856.
   PubMed Web of Science ®Google Scholar
• Li Q, Li X, Wang J, et al. Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open. 2019;9(8):e026677. doi:10.1136/bmjopen-2018-026677
   PubMed Web of Science ®Google Scholar
• Taguchi I, Iimuro S, Iwata H, et al. High-dose versus low-dose pitavastatin in Japanese patients with stable Coronary Artery Disease (REAL-CAD): a randomized superiority trial. Circulation. 2018;137(19):1997–2009. doi:10.1161/CIRCULATIONAHA.117.032615
   PubMed Web of Science ®Google Scholar
• Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003;42(4):474–480. doi:10.1161/01.HYP.0000091371.53502.D3
   PubMed Web of Science ®Google Scholar
• Puig JG, Martinez MA. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol. 2008;20(2):187–191. doi:10.1097/BOR.0b013e3282f4b1ed
   PubMed Web of Science ®Google Scholar
• Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–390. doi:10.1038/s41584-020-0441-1
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Bakris GL, Borghi C, et al. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. Am J Kidney Dis. 2018;71(6):851–865. doi:10.1053/j.ajkd.2017.12.009
   PubMed Web of Science ®Google Scholar
• Tanaka K, Ogata S, Tanaka H, et al. The relationship between body mass index and uric acid: a study on Japanese adult twins. Environ Health Prev Med. 2015;20(5):347–353. doi:10.1007/s12199-015-0473-3
   PubMed Web of Science ®Google Scholar
• Wang H, Lizhen WA, Rui XI, et al. Association of serum uric acid with body mass index: a cross-sectional study from Jiangsu Province, China. Iran J Public Health. 2014;43(11):1503–1509.
   PubMed Web of Science ®Google Scholar
• Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47(8):929–933. doi:10.1016/S0026-0495(98)90346-8
   PubMed Web of Science ®Google Scholar
• Fabregat I, Revilla E, Machado A. Short-term control of the pentose phosphate cycle by insulin could be modulated by the NADPH/NADP ratio in rat adipocytes and hepatocytes. Biochem Biophys Res Commun. 1987;146(2):920–925. doi:10.1016/0006-291X(87)90618-8
   PubMed Web of Science ®Google Scholar
• Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD Epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010;56:32–38. doi:10.1053/j.ajkd.2010.02.344
   PubMed Web of Science ®Google Scholar
• KDIGO. 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1–150.
   Web of Science ®Google Scholar